Detail akcie Clearmind Medcn Rg online

Business Summary: Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Financial Summary: BRIEF: For the fiscal year ended 31 October 2025, Clearmind Medicine Inc revenues was not reported. Net loss decreased 27% to $3.9M. Lower net loss reflects Changes in fair value of short-term inve increase from $69K (expense) to $845K (income), Changes in fair value of derivative warr increase of 59% to $1.1M (income), Share-based compensation decrease of 35% to $724K (expense).